Cox KM - Search Results

1

The impact of histological review on clinical management of testicular cancer.

Segelov E, Cox KM, Raghavan D, McNeil E, Lancaster L, Rogers J. Segelov E, et al. Among authors: cox km. Br J Urol. 1993 Jun;71(6):736-8. doi: 10.1111/j.1464-410x.1993.tb16076.x. Br J Urol. 1993. PMID: 8393729

2

Multiple atypical nevi: a cutaneous marker of germ cell tumors.

Raghavan D, Zalcberg JR, Grygiel JJ, Teriana N, Cox KM, McCarthy W, Flynn M. Raghavan D, et al. Among authors: cox km. J Clin Oncol. 1994 Nov;12(11):2284-7. doi: 10.1200/JCO.1994.12.11.2284. J Clin Oncol. 1994. PMID: 7964941

3

The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study.

Smith AB, King M, Butow P, Luckett T, Grimison P, Toner GC, Stockler M, Hovey E, Stubbs J, Hruby G, Gurney H, Turner S, Alam M, Cox K, Olver I. Smith AB, et al. Psychooncology. 2013 Nov;22(11):2557-64. doi: 10.1002/pon.3323. Epub 2013 Jul 3. Psychooncology. 2013. PMID: 23825010

4

The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study.

Smith AB, Butow P, Olver I, Luckett T, Grimison P, Toner GC, Stockler MR, Hovey E, Stubbs J, Turner S, Hruby G, Gurney H, Alam M, Cox K, King MT. Smith AB, et al. J Cancer Surviv. 2016 Apr;10(2):223-33. doi: 10.1007/s11764-015-0468-5. Epub 2015 Jul 16. J Cancer Surviv. 2016. PMID: 26178326

5

Nurse-led supportive care management: a 6-month review of the role of a nurse practitioner in a chemotherapy unit.

Cox K, Karikios D, Roydhouse JK, White K. Cox K, et al. Aust Health Rev. 2013 Nov;37(5):632-5. doi: 10.1071/AH13069. Aust Health Rev. 2013. PMID: 24176186

6

Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur.

Boyer MJ, Cox K, Tattersall MH, Findlay MP, Grygiel J, Rogers J. Boyer MJ, et al. Urology. 1997 Oct;50(4):588-92. doi: 10.1016/S0090-4295(97)00301-4. Urology. 1997. PMID: 9338737

7

Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature.

Vardy J, Engelhardt K, Cox K, Jacquet J, McDade A, Boyer M, Beale P, Stockler M, Loneragan R, Dennien B, Waugh R, Clarke SJ. Vardy J, et al. Br J Cancer. 2004 Sep 13;91(6):1045-9. doi: 10.1038/sj.bjc.6602082. Br J Cancer. 2004. PMID: 15316563 Free PMC article. Review.

8

Establishing a programme for continuous ambulatory infusion chemotherapy.

Cox K, Visintin L, Kovac S, Childs A, Kelleher H, Murray B, White G, Storey D, Findlay M. Cox K, et al. Aust N Z J Med. 1997 Dec;27(6):680-4. doi: 10.1111/j.1445-5994.1997.tb00998.x. Aust N Z J Med. 1997. PMID: 9483236

9

The management of cytotoxic-drug extravasation: guide-lines drawn up by a working party for the Clinical Oncological Society of Australia.

Cox K, Stuart-Harris R, Abdini G, Grygiel J, Raghavan D. Cox K, et al. Med J Aust. 1988 Feb 15;148(4):185-9. Med J Aust. 1988. PMID: 3277019 Review. No abstract available.

10

Phase II clinical trial of recombinant alpha-2 interferon for biopsy-proven metastatic or recurrent renal carcinoma.

Rosenthal MA, Cox K, Raghavan D, Grygiel JJ, Wines RD, Mameghan H, Rogers J. Rosenthal MA, et al. Br J Urol. 1992 May;69(5):491-4. doi: 10.1111/j.1464-410x.1992.tb15594.x. Br J Urol. 1992. PMID: 1623377 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results